Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Return on Capital Employed: 2020-2025

Historic Return on Capital Employed for Biodesix (BDSX) over the last 5 years, with Sep 2025 value amounting to -0.46%.

  • Biodesix's Return on Capital Employed fell 10.00% to -0.46% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.46%, marking a year-over-year decrease of 10.00%. This contributed to the annual value of -0.41% for FY2024, which is 25.00% up from last year.
  • Latest data reveals that Biodesix reported Return on Capital Employed of -0.46% as of Q3 2025, which was up 2.13% from -0.47% recorded in Q2 2025.
  • Biodesix's Return on Capital Employed's 5-year high stood at -0.20% during Q1 2021, with a 5-year trough of -1.52% in Q3 2022.
  • For the 3-year period, Biodesix's Return on Capital Employed averaged around -0.60%, with its median value being -0.47% (2025).
  • In the last 5 years, Biodesix's Return on Capital Employed slumped by 115bps in 2022 and then surged by 62bps in 2024.
  • Quarterly analysis of 5 years shows Biodesix's Return on Capital Employed stood at -0.76% in 2021, then dropped by 16bps to -0.92% in 2022, then grew by 22bps to -0.69% in 2023, then increased by 29bps to -0.40% in 2024, then fell by 10bps to -0.46% in 2025.
  • Its Return on Capital Employed was -0.46% in Q3 2025, compared to -0.47% in Q2 2025 and -0.42% in Q1 2025.